Semaglutide, Tirzepatide, Retatrutide, AOD9604, Cagrilintide, and metabolic research compounds.
A source-dated explanation of TRIUMPH-1 design, week 80 retatrutide results, estimands, extension limits, safety signals, and regulatory status.
Retatrutide TRIUMPH-1 Phase 3 Results: What the 2026 Data Show Read More ยป
An evidence-scoped Survodutide guide covering BI 456906 identity, dual GCGR/GLP-1R biology, obesity and MASH evidence, and current development status.
Survodutide Research Guide: Dual GCGR/GLP-1R Evidence Read More ยป
An evidence-led mazdutide guide covering dual GLP-1/glucagon pharmacology, GLORY-1 and DREAMS results, China approvals, comparison boundaries, and RUO material context.
Mazdutide Research Guide: Dual Agonism, Trials, and 2026 Status Read More ยป
An evidence-led guide to cagrilintide and CagriSema, including molecular identity, amylin and GLP-1 rationale, clinical trials, result interpretation, and regulatory status.
Cagrilintide and CagriSema Research Guide Read More ยป
A source-dated landscape of next-generation GLP-1 research architectures, evidence lanes, program status, and molecule-specific guide handoffs.
Next-Generation GLP-1 Research: Classes, Evidence, and 2026 Status Read More ยป
An evidence-led guide to SLU-PP-332 as a small-molecule pan-ERR chemical probe, with model-specific findings and a symmetric SLU-PP-915 comparison.
SLU-PP-332 Research Guide: A Pan-ERR Agonist Read More ยป
An evidence-scoped guide to 5-Amino-1MQ identity, NNMT biology, direct cell and mouse studies, human evidence gaps, and research-grade documentation.
5-Amino-1MQ Research Guide: NNMT Evidence, Mechanism, and Limits Read More ยป
An evidence-led comparison of Liraglutide C16 acylation and Dulaglutide Fc-fusion engineering, the direct AWARD-6 trial, distinct evidence programs, and current regulatory identities.
Liraglutide vs Dulaglutide: Structure, Pharmacology, and AWARD-6 Evidence Read More ยป
An evidence-led Semaglutide research guide covering molecular design, selective GLP-1 receptor mechanism, SUSTAIN, PIONEER, STEP, SELECT, and the U.S. FDA record through March 2026.
Semaglutide Research Guide: Molecular Design, GLP-1R Mechanism & Evidence Read More ยป
A symmetric semaglutide, tirzepatide, and retatrutide comparison covering single, dual, and triple receptor architecture, direct evidence, cross-trial limits, and July 2026 status.
Semaglutide vs Tirzepatide vs Retatrutide: Single, Dual, and Triple Agonists Compared Read More ยป
An evidence-led map of GLP-1 mono-agonists, dual and triple agonists, GLP-1/glucagon programs, amylin combinations, and adjacent metabolic tools.
GLP-1 / Metabolic Research Peptides: Family and Evidence Guide Read More ยป
An evidence-scoped Tirzepatide guide covering GIPR/GLP-1R pharmacology, representative SURPASS and SURMOUNT research, and current FDA formulation boundaries.
Tirzepatide Research Guide: GIP/GLP-1 Pharmacology and FDA Status Read More ยป
A current Retatrutide-versus-Tirzepatide comparison covering receptor scope, evidence maturity, FDA status, and the pending TRIUMPH-5 head-to-head study.
Retatrutide vs Tirzepatide: Mechanism, Evidence, and Approval Status Read More ยป
Comprehensive research guide to AOD9604, the modified human growth hormone fragment 176-191. CAS 221231-10-3, MW 1815.08 g/mol. Lipolytic mechanism without IGF-1 stimulation, published metabolic data, comparison to full-length hGH and HGH Fragment 176-191, and research protocols.
AOD9604 Research Guide: Identity, Evidence, and Human Limits Read More ยป
Comprehensive Retatrutide (LY3437943) guide covering GIP/GLP-1/glucagon triple-receptor pharmacology, peer-reviewed Phase 2 evidence, July 2026 Phase 3 status, comparisons, limitations, and research-material verification.
A symmetric semaglutide-versus-tirzepatide comparison covering receptor design, SURPASS-2 and SURMOUNT-5, evidence limits, and regulatory identity.
Semaglutide vs Tirzepatide: Mechanism and Head-to-Head Evidence Read More ยป
Same day shipping
Multiple payment options
Real-time order tracking
Weโre here to help
Apex Laboratory is a specialized supplier of high-purity chemical reagents and peptides. All products listed are strictly for in-vitro laboratory research and development use only.
